|
MSF Field Research >
1 Published Research and Commentary >
Other Diseases >
Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence.
Please use
this identifier to cite or link
to this item:
http://hdl.handle.net/10144/204590
 Del.icio.us
 LinkedIn
 Citeulike
 Connotea
 Facebook
 Stumble it!
| Download this article: |
| View/Open |
File |
Description |
Size |
Format |
View/Open | Ritmeijer Limited Eff Amph B Leish Ethiopia CID.pdf | | 256Kb | Adobe PDF |
|
| Title: | Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence. |
| Authors: | Ritmeijer, Koert
ter Horst, Rachel
Chane, Solomon
Aderie, Endashaw Mengistu
Piening, Turid
Collin, Simon M
Davidson, Robert N |
| Affiliation: | Public Health Department, Médecins Sans Frontières, Amsterdam, the Netherlands. koert.ritmeijer@amsterdam.msf.org |
| Citation: | Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence. 2011, 53 (12):e152-8 Clin. Infect. Dis. |
| Journal: | Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America |
| Issue Date: | Dec-2011 |
| URI: | http://hdl.handle.net/10144/204590 |
| DOI: | 10.1093/cid/cir674 |
| PubMed ID: | 22016502 |
| Abstract: | Due to unacceptably high mortality with pentavalent antimonials, Médecins Sans Frontières in 2006 began using liposomal amphotericin B (AmBisome) for visceral leishmaniasis (VL) patients in Ethiopia who were severely ill or positive for human immunodeficiency virus (HIV). |
| Language: | en |
| ISSN: | 1537-6591 |
| Rights: | Published by: Infectious Diseases Society of America and University of Chicago Press
Archived on this site with permission and copyright 2011 by the Infectious Diseases Society of America |
| Appears in topics: | Other Diseases
|
| Related articles on PubMed | | | | |  | Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.Sinha PK, van Griensven J, Pandey K, Kumar N, Verma N, Mahajan R, Kumar P, Kumar R, Das P, Mitra G, Flevaud L, Ferreyra C, Remartinez D, Pece M, Palma PP 2011 Oct |
| | See all 137 articles |
All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.
|
